• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】15715

【品名】4-Aminophenol

【CA登记号】123-30-8

【 分 子 式 】C6H7NO

【 分 子 量 】109.12772

【元素组成】C 66.04% H 6.47% N 12.84% O 14.66%

与该中间体有关的原料药合成路线共 8 条

合成路线1

该中间体在本合成路线中的序号:(III)

The reaction of retinoic acid (I) with PCl3 in dry benzene gives the corresponding retinoyl chloride (II), which is then condensed with 4-aminophenol (III) in DMF - ether.

1 Gander, R.J.; Gurney, J.A.; Esters of retinoic acid. BE 0847942; CA 1062700; GB 1543824; NL 7612201; US 4108880 .
2 Hillier, K.; Blancafort, P.; Serradell, M.N.; Castaner, J.; 4-Hydroxyphenylretinamide. Drugs Fut 1980, 5, 3, 132.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 32679 (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; Retinoic acid 302-79-4 C20H28O2 详情 详情
(II) 32680 Retinoyl chloride; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoyl chloride C20H27ClO 详情 详情
(III) 15715 4-Aminophenol 123-30-8 C6H7NO 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

The condensation of 4-aminophenol (I) with 2-chloro-3-nitropyridine (II) in DMF at 100 C gives 4-(3-nitropyridin-2-ylamino)phenol (III), which is reduced with H2 over Pd/C in THF-methanol to afford 4-(3-aminopyridin-2-ylamino)phenol (IV). Finally, this compound is condensed with 4-methoxybenzenesulfonylchloride (V) by means of pyridine in THF.

1 Yoshino, H.; Ueda, N.; Sugumi, H.; Niijima, J.; Kotake, Y.; Okada, T.; Koyanagi, N.; Watanabe, T.; Asada, M.; Yoshimatsu, K.; Iijima, A.; Nagasu, T.; Tsukahara, K.; Kitoh, K. (Eisai Co., Ltd.); Sulfonamide derivs. EP 0472053; JP 1993039256; US 5250549; US 5292758; US 5332751; US 5434172 .
2 Niijima, J.; Yoshino, H.; Ueda, N.; et al.; Novel sulfonamides as potential, systemically active antitumor agents. J Med Chem 1992, 35, 13, 2496-7.
3 Hoshi, A.; Castaner, J.; E-7010. Drugs Fut 1993, 18, 11, 995.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 15715 4-Aminophenol 123-30-8 C6H7NO 详情 详情
(II) 10321 2-Chloro-3-nitropyridine 5470-18-8 C5H3ClN2O2 详情 详情
(III) 15717 4-[(3-nitro-2-pyridinyl)amino]phenol C11H9N3O3 详情 详情
(IV) 15718 4-[(3-amino-2-pyridinyl)amino]phenol C11H11N3O 详情 详情
(V) 15719 4-methoxybenzenesulfonyl chloride 98-68-0 C7H7ClO3S 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

Imine (III) was prepared by condensation of 6-methoxy-1-tetralone (I) with p-aminophenol (II) at 180 C. After silylation of the hydroxyl group of (III) with tert-butyldimethylsilyl chloride to give (IV), acylation of the enamine function with 2-bromo-5-methoxybenzoyl chloride (V) yielded enamide (VI). Halogenation of (VI) with N-bromosuccinimide gave the beta-bromo enamide (VII). Photocyclization of (VII) produced the benzophenanthridine (VIII), which was further dehydrogenated with DDQ providing (IX). Desilylation of (IX) to afford phenol (X) was achieved by treatment with hydrogen fluoride-pyridine.

1 Grese, T.A.; et al.; Photochemical synthesis of N-arylbenzophenanthridine selective estrogen receptor modulators (SERMs). J Med Chem 2001, 44, 17, 2857.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 17594 6-methoxy-3,4-dihydro-1(2H)-naphthalenone; 6-Methoxytetralone; 6-Methoxy-1-tetralone; 3,4-dihydro-6-methoxy-1(2H)-naphthalenone 1078-19-9 C11H12O2 详情 详情
(II) 15715 4-Aminophenol 123-30-8 C6H7NO 详情 详情
(III) 50224 4-[[6-methoxy-3,4-dihydro-1(2H)-naphthalenylidene]amino]phenol C17H17NO2 详情 详情
(IV) 50225 N-(4-[[tert-butyl(dimethyl)silyl]oxy]phenyl)-N-[6-methoxy-3,4-dihydro-1(2H)-naphthalenylidene]amine; 4-[[tert-butyl(dimethyl)silyl]oxy]-N-[6-methoxy-3,4-dihydro-1(2H)-naphthalenylidene]aniline C23H31NO2Si 详情 详情
(V) 50226 2-Bromo-5-methoxybenzoyl chloride 56658-04-9 C8H6BrClO2 详情 详情
(VI) 50227 2-bromo-N-(4-[[tert-butyl(dimethyl)silyl]oxy]phenyl)-5-methoxy-N-(6-methoxy-3,4-dihydro-1-naphthalenyl)benzamide C31H36BrNO4Si 详情 详情
(VII) 50228 2-bromo-N-(2-bromo-6-methoxy-3,4-dihydro-1-naphthalenyl)-N-(4-[[tert-butyl(dimethyl)silyl]oxy]phenyl)-5-methoxybenzamide C31H35Br2NO4Si 详情 详情
(VIII) 50229 5-(4-[[tert-butyl(dimethyl)silyl]oxy]phenyl)-2,8-dimethoxy-11,12-dihydrobenzo[c]phenanthridin-6(5H)-one C31H35NO4Si 详情 详情
(IX) 50230 5-(4-[[tert-butyl(dimethyl)silyl]oxy]phenyl)-2,8-dimethoxybenzo[c]phenanthridin-6(5H)-one C31H33NO4Si 详情 详情
(X) 50231 5-(4-hydroxyphenyl)-2,8-dimethoxybenzo[c]phenanthridin-6(5H)-one C25H19NO4 详情 详情

合成路线4

该中间体在本合成路线中的序号:(VII)

4,5-Dimethoxy-2-nitrobenzoic acid (I) was treated with thionyl chloride to form acid chloride (II), followed by reaction with ammonia to yield 4,5-dimethoxy-2-nitrobenzamide (III). This was reduced with sodium borohydride in the presence of copper sulfate to give aminobenzamide (IV), which was refluxed with formic acid to afford 6,7-dimethoxyquinazoline-4(3H)-one (V). Subsequent treatment of (V) with phosphoryl chloride gave the chloroquinazoline (VI). The title compound was then prepared by condensation of (VI) with 4-aminophenol (VII) in refluxing ethanol.

1 Liu, X.-P.; Narla, R.K.; Uckun, F.M. (Parker Hughes Institute); Quinazolines for treating brain tumor. WO 9961428 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 31789 4,5-dimethoxy-2-nitrobenzoic acid 4998-07-6 C9H9NO6 详情 详情
(II) 31790 4,5-dimethoxy-2-nitrobenzoyl chloride C9H8ClNO5 详情 详情
(III) 31791 4,5-dimethoxy-2-nitrobenzamide 4959-60-8 C9H10N2O5 详情 详情
(IV) 31792 2-amino-4,5-dimethoxybenzamide 5004-88-6 C9H12N2O3 详情 详情
(V) 18684 6,7-dimethoxy-4(3H)-quinazolinone 13794-72-4 C10H10N2O3 详情 详情
(VI) 23765 4-chloro-6,7-dimethoxyquinazoline; 4-chloro-6-methoxy-7-quinazolinyl methyl ether C10H9ClN2O2 详情 详情
(VII) 15715 4-Aminophenol 123-30-8 C6H7NO 详情 详情

合成路线5

该中间体在本合成路线中的序号:(IV)

The cyclocondensation of triphenylphosphite (I) with 4-(benzyloxycarbonyl-L-prolylamino)butyraldehyde (II) in hot acetic acid gives the pyrrolidinylphosphonate (III), which is deprotected by hydrogenation with H2 over Pd/C in methanol. The intermediates (I) and (II) have been obtained as follows: Phosphite (I): The acylation of 4-aminophenol (IV) with acetic acid and isobutyl chloroformate in DMF gives N-(4-hydroxyphenyl)acetamide (V), which is allowed to react with PCl3 and triethylamine in DMF yielding phosphite (I). 4-(Benzyloxycarbonyl-L-prolylamino)butyraldehyde (II): The condensation of N-(benzyloxycarbonyl)-L-proline (VI) with 4-aminobutyraldehyde diethylacetal (VII) by means of isobutyl chloroformate and triethylamine in chloroform gives 4-[N-(benzyloxycarbonyl)-L-prolylamino]butyraldehyde diethylacetal (VIII), which is hydrolyzed to the target aldehyde (II) with HCl in THF.

1 De Meester, I.; Augustyns, K.; Haemers, A.; Zhang, X.; Vedernikova, I.; Belyaev, A.; Scharpé, S.; Lambeir, A.-M.; Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors. J Med Chem 1999, 42, 6, 1041.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 26634 tris[4-(acetamido)phenyl] phosphite C24H24N3O6P 详情 详情
(II) 26635 benzyl (2S)-2-[[(4-oxobutyl)amino]carbonyl]-1-pyrrolidinecarboxylate C17H22N2O4 详情 详情
(III) 26636 benzyl (2S)-2-[(2-[bis[4-(acetamido)phenoxy]phosphoryl]-1-pyrrolidinyl)carbonyl]-1-pyrrolidinecarboxylate C33H37N4O8P 详情 详情
(IV) 15715 4-Aminophenol 123-30-8 C6H7NO 详情 详情
(V) 21611 4'-Hydroxyacetanilide;4-Acetamidophenol;N-Acetyl-4-aminophenol;Paracetamol;Acetaminophen;p-Hydroxyacetanilide; Paracetamol; N-(4-hydroxyphenyl)acetamide 103-90-2 C8H9NO2 详情 详情
(VI) 17005 (2R)-1-[(benzyloxy)carbonyl]tetrahydro-1H-pyrrole-2-carboxylic acid C13H15NO4 详情 详情
(VII) 23323 4,4-diethoxybutylamine; 4,4-diethoxy-1-butanamine 6346-09-4 C8H19NO2 详情 详情
(VIII) 26637 benzyl (2S)-2-[[(4,4-diethoxybutyl)amino]carbonyl]-1-pyrrolidinecarboxylate C21H32N2O5 详情 详情

合成路线6

该中间体在本合成路线中的序号:(II)

The condensation of 4-chloro-2-(2-naphthyl)quinoline (I) with p-aminophenol (II) at 130 C provided the corresponding 4-anilinoquinoline (III). Then, Mannich reaction of (III) with N-methylpiperazine (IV) and formaldehyde furnished the title compound.

1 Kotecka, B.M.; Strekowski, L.; Say, M.; Manzel, L.; Henary, M.; Zegrocka, O.; Macfarlane, D.E.; Mokrosz, M.J.; Structure-activity relationship analysis of substituted 4-quinolinamines, antagonists of immunostimulatory CpG-oligodeoxynucleotides. Bioorg Med Chem Lett 1999, 9, 13, 1819.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 34398 4-chloro-2-(2-naphthyl)quinoline C19H12ClN 详情 详情
(II) 15715 4-Aminophenol 123-30-8 C6H7NO 详情 详情
(III) 34399 4-[[2-(2-naphthyl)-4-quinolinyl]amino]phenol C25H18N2O 详情 详情
(IV) 10061 1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine 109-01-3 C5H12N2 详情 详情

合成路线7

该中间体在本合成路线中的序号:(I)

Condensation of 4-aminophenol (I) with 4-chloropyridine (II) in the presence of potassium tert-butoxide afforded the intermediate diaryl ether (III).

1 Redman, A.; Paulsen, H.; Lowinger, T.B.; Dumas, J.; Johnson, J.; Wood, J.E.; Scott, W.J.; Khire, U.; Hatoum-Mokdad, H.; Lee, W.; Smith, R.A.; Riedl, B. (Bayer Corp.); Inhibition of raf kinase using substd. heterocyclic ureas. EP 1047418; WO 9932106 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 15715 4-Aminophenol 123-30-8 C6H7NO 详情 详情
(II) 32889 4-chloropyridine 7379-35-3 C5H4ClN 详情 详情
(III) 47254 4-(4-pyridinyloxy)aniline; 4-(4-pyridinyloxy)phenylamine C11H10N2O 详情 详情

合成路线8

该中间体在本合成路线中的序号:(IV)

 

1 Wilhelm S. 2007. Use of sorafenib for the treatment of cancers having resisunce to chemotherapeutic agents. W0 2007059155
2 Bankston D, Dumas J, Natero R, et al. 2002. A scaleable synthesis of BAY 43-9006: a potent raf kinase inhibitor for the treatment of cancer. Org Proc Dev, 6(6):777~781
3 Logers M, Gehring R, Kuhn O, et al. 2006. Process for the preparation of 4-[4-[[[[4-chloro-3-(trifluoromethyl) phenyl]amino]carbonyl]amino]phenoxy]-N-methylpyridine-2-carboxamide and its tosylate salt. WO 2006034796
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 29950 2-pyridinecarboxylic acid;picolinic acid;Pyridine-2-carboxylic acid 98-98-6 C6H5NO2 详情 详情
(II) 49908 4-chloropyridine-2-carbonyl chloride hydrochloride;(4-Chloro-2-pyridinecarbonyl Chloride Hydrochloride);4-Chloro-2-pyridinecarbonyl Chloride Hydrochlorid 51727-15-2 C6H3Cl2NO.HCl 详情 详情
(III) 49910 4-chloro-N-methyl-2-pyridinecarboxamide;4-chloro-N-methylpyridine-2-carboxamide;4-chloro-N-methylpicolinamide;4-Chloro-N-methylpicolinamide;2-(N-Methylcarbamoyl)-4-chloropyridine;4-Chloropyridine-2-carboxylicacid methylamide;N-Methyl-4-chloro-2-pyridinecarboxamide;N-Methyl-4-chloropicolinamide 220000-87-3 C7H7ClN2O 详情 详情
(IV) 15715 4-Aminophenol 123-30-8 C6H7NO 详情 详情
(V) 49912 4-(4-aminophenoxy)-N-methyl-2-pyridinecarboxamide 284462-37-9 C13H13N3O2 详情 详情
(VI) 37868 1-chloro-4-isocyanato-2-(trifluoromethyl)benzene; 4-chloro-3-(trifluoromethyl)phenyl isocyanate 327-78-6 C8H3ClF3NO 详情 详情
(VII) 66747 4-[4-[3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido]phenoxy]-N-methylpyridine-2-carboxamide 284461-73-0 C21H16ClF3N4O3 详情 详情
Extended Information